In case you missed it: Jan. 18 to Jan. 22
It was a very busy week for the Contemporary OB/GYN® team.
This week's top articles included:
Using telemedicine for contraception
In response to the coronavirus disease 2019 pandemic, many U.S. family planning providers have started offering telemedicine services.
COVID-19 in pregnancy: What ob/gyns should know about the vaccines
In this video, Senior Editor Angie DeRosa interviews Emily Adhikari, MD, on questions or concerns she and colleagues are hearing from patients surrounding the COVID-19 vaccine.
Cognitive changes in menopause: with and without HIV
Women with HIV are no more vulnerable to menopause-related cognitive declines compared to other women, according to a longitudinal cohort study in the journal Menopause.
Cannabis use may reduce conception efforts
Marijuana use may make conception more difficult for women who smoke than those who don’t, according to a prospective cohort study from the National Institutes of Health (NIH).
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More
